Boston Scientific Corporation

BSX·NYSE·$57.64Share Price as of 11/2·$86BMarket Cap as of 11/2

Financials

10-QQ2 ended 06/30/2608/03/26 10-QQ1 ended 03/31/2605/01/26 10-KFY 202502/17/26 10-QQ3 ended 09/30/2511/03/25 10-QQuarterly Report08/01/25

Disclosures

8-KCurrent report10/28/26 8-KCurrent report10/07/26 8-KCurrent report09/23/26 8-KCurrent report09/08/26 8-KCurrent report08/26/26

Prospectuses and Registrations

S-8Registration of securities for employees05/08/26 424B3Prospectus04/01/26 S-4/ARegistration (business combination, amended)03/30/26 S-4Registration (business combination)02/27/26 424B2Prospectus for primary offering02/24/25

Proxies

DEF 14ADefinitive proxy03/18/26 DEFA14AAdditional proxy materials03/18/26 PRE 14APreliminary proxy03/06/26 DEF 14ADefinitive proxy03/19/25 DEFA14AAdditional proxy materials03/19/25

Ownership

Form 4Insider transaction09/03/26 Form 4Insider transaction08/26/26 Form 4Insider transaction08/12/26 Form 4Insider transaction08/11/26 Form 4Insider transaction08/07/26

Other

11-KEmployee stock purchase plan report06/24/26 SDConflict Minerals disclosure05/21/26 42542504/22/26 EFFECTRequest for effectiveness04/01/26 CORRESPCorrespondence with the SEC03/30/26